Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients:...
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group
About this item
Full title
Author / Creator
Pepe, Sara , Rossi, Elena , Trawinska, Malgorzata , Tatarelli, Caterina , Di Veroli, Ambra , Maurillo, Luca , Romano, Atelda , Crescenzi, Sabrina Leonetti , di Toritto, Tommaso Caravita , Tafuri, Agostino , Latagliata, Roberto , Scalzulli, Emilia , Andriani, Alessandro , De Stefano, Valerio and Breccia, Massimo
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Ruxolitinib is approved for polycythemia vera (PV) patients after failure to previous cytoreductive therapy, based on durable results observed in phase 3 trials. We report a multicenter retrospective study demonstrating the efficacy and safety of ruxolitinib in real-life setting. Eighty-three patients were evaluated. Median follow-up was 24.5 month...
Alternative Titles
Full title
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2642324352
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2642324352
Other Identifiers
ISSN
0939-5555
E-ISSN
1432-0584
DOI
10.1007/s00277-022-04815-w
